Biotech downturn hurts companies targeting autism-linked conditions

After a year of intense growth, funding for biotech is in decline. The result is layoffs and program cuts — and maybe some innovation.

Episode metadata supplied by the publisher feed · Published Feb 23, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Biotech downturn hurts companies targeting autism-linked conditions

0:00 7:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 7 minutes long.

This episode was published on February 23, 2023.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!